DR. EDWIN ANDERSON KEEL MD NPI 1720067739

NPI Details

DR. Edwin Anderson Keel, MD is a family medicine in Oxford, AL with 39 years of experience. The provider is family Medicine is the medical specialty which is concerned with the total health care of the individual and the family. It is the specialty in breadth which integrates the biological, clinical, and behavioral sciences. The scope of family medicine is not limited by age, sex, organ system, or disease entity. DR. Edwin Anderson Keel, MD NPI is 1720067739. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: MEDICAL COLLEGE OF GEORGIA SCHOOL OF MEDICINE
Graduation Year:1986

The provider's business location address is:

1612 US HIGHWAY 78 E
SUITE 100
OXFORD, AL
ZIP 36203-862
Phone: (256) 835-4756
Fax: (256) 831-5736

The NPI 1720067739 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Injection, testosterone cypionate, 1 mg (HCPCS:J1071)
• Injection of drug or substance under skin or into muscle (HCPCS:96372)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Injection, ceftriaxone sodium, per 250 mg (HCPCS:J0696)
• Injection, ketorolac tromethamine, per 15 mg (HCPCS:J1885)
• Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg (HCPCS:J0702)
• Detection test by immunoassay with direct visual observation for influenza virus (HCPCS:87804)
• Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count (HCPCS:85025)
• Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) (HCPCS:87811)
• Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) (HCPCS:87880)
• Established patient office or other outpatient visit, 20-29 minutes (HCPCS:99213)
• Injection, triamcinolone acetonide, not otherwise specified, 10 mg (HCPCS:J3301)
• Blood test, comprehensive group of blood chemicals (HCPCS:80053)
• Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg (HCPCS:J3420)
• X-ray of chest, 2 views (HCPCS:71046)
• Blood test, lipids (cholesterol and triglycerides) (HCPCS:80061)
• Automated urinalysis test (HCPCS:81003)
• Injection, ondansetron hydrochloride, per 1 mg (HCPCS:J2405)
• Hemoglobin a1c level (HCPCS:83036)
• Inhalation treatment for airway obstruction or sputum production (HCPCS:94640)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Injection, cefazolin sodium, 500 mg (HCPCS:J0690)
• Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus (HCPCS:87426)
• Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report (HCPCS:93000)
• Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen (HCPCS:87635)
• Insertion of needle into vein for collection of blood sample (HCPCS:36415)
• Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free (HCPCS:90674)
• Aspiration and/or injection of fluid from large joint (HCPCS:20610)
• X-ray of lower and sacral spine, minimum of 4 views (HCPCS:72110)
• Administration of influenza virus vaccine (HCPCS:G0008)
• X-ray of hip, 2-3 views (HCPCS:73502)
• Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme (HCPCS:J7620)
• New patient office or other outpatient visit, 30-44 minutes (HCPCS:99203)
• X-ray of shoulder, minimum of 2 views (HCPCS:73030)
• Blood glucose (sugar) measurement using reagent strip (HCPCS:82948)
• Analysis for antibody to helicobacter pylori (gastrointestinal bacteria) (HCPCS:86677)

The enumeration date for this NPI number is 1/10/2006 and was last updated on 1/14/2013.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.